| Model Number |
FR995-29 |
| Medical Device Problem Codes |
Patient Device Interaction Problem (4001); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Chest Pain (1776); Dyspnea (1816); Dizziness (2194); Aortic Valve Insufficiency/ Regurgitation (4450)
|
| Date of Event |
07/30/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Additional information was received that the patient successfully had a 34mm aortic transcatheter valve-in-valve replacement.No additional adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
It was reported that 8 years and 2 months post implant of this 29mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was reported as leaflet prolapse, moderate to severe aortic insufficiency, congestive heart failure and hemodynamic instability.It was noted that the patient also experienced shortness of breath on exertion with intermittent chest pressure and light headedness.It was further noted that the computed tomography (ct) scan showed an increase in size of ascending aorta from 4.5cm to 5.4cm.It was reported that medical therapy was provided to the patient.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
B1,b5 and imf (annex f) codes were updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|